| 陈铭睿,韩颖颖,林 玲,等.2021年江苏省南通市前列腺癌发病和死亡特征及2013—2021年趋势分析[J].肿瘤学杂志,2025,31(8):725-731. |
| 2021年江苏省南通市前列腺癌发病和死亡特征及2013—2021年趋势分析 |
| Incidence and Mortality of Prostate Cancer in Nantong City，Jiangsu Province in 2021 and the Trend from 2013 to 2021 |
| 投稿时间：2025-02-24 |
| DOI：10.11735/j.issn.1671-170X.2025.08.B011 |
|
 |
| 中文关键词: 前列腺肿瘤 发病 死亡 趋势分析 江苏 |
| 英文关键词:prostate neoplasms incidence mortality trend analysis Jiangsu |
| 基金项目: |
|
| 摘要点击次数: 205 |
| 全文下载次数: 94 |
| 中文摘要: |
| 摘 要：［目的］ 分析江苏省南通市2021年前列腺癌的发病及死亡特征，以及2013—2021年变化趋势。［方法］ 通过南通市肿瘤登记报告系统收集2013—2021年南通市前列腺癌发病和死亡资料，分别城乡分层计算粗发病（死亡）率、中标人口标化发病（死亡）率、世界人口标化发病（死亡）率、35~64岁截缩率、0~74岁累积率等；采用2000年第五次全国人口普查数据和Segi’s 1960世界标准人口构成分别计算中标率和世标率；采用Joinpoint 4.9.1.0软件计算前列腺癌中标发病（死亡）率平均年度变化百分比（average annual percentage change，AAPC），并分析变化趋势。［结果］ 2021年南通市前列腺癌粗发病率为41.18/10万，中标发病率为12.62/10万，世标发病率为12.32/10万；粗死亡率为13.42/10万，中标死亡率为3.40/10万，世标死亡率为3.56/10万；城市地区发病率和死亡率均高于农村地区。前列腺癌年龄别发病率在80~84岁年龄组达到高峰，年龄别死亡率在85岁及以上年龄组达到高峰。2013—2021年南通市前列腺癌发病水平呈现明显上升趋势，中标发病率AAPC为6.86%（P＜0.001）；前列腺癌死亡水平也呈明显上升趋势，中标死亡率AAPC为3.83%（P=0.020）。55~59岁、60~64岁、65~69岁、70~74岁、75~79岁、80~84岁和85岁及以上各年龄组前列腺癌发病率均呈上升趋势（AAPC分别为9.44%、9.14%、10.41%、7.85%、6.13%、6.83%和2.75%，P均＜0.05），仅80~84岁和85岁及以上年龄组死亡率呈上升趋势（AAPC分别为6.63%及8.73%，P均＜0.05）。［结论］ 南通市前列腺癌疾病负担处于较高水平，发病率和死亡率呈逐年上升趋势，应重点关注中老年男性群体，加强前列腺癌筛查与早诊早治工作。 |
| 英文摘要: |
| Abstract：［Objective］ To analyze the incidence and mortality of prostate cancer in Nantong City of Jiangsu Province in 2021 and the trend from 2013 to 2021. ［Methods］ Data on the incidence and mortality of prostate cancer in Nantong City from 2013 to 2021 were collected through the Nantong Cancer Registry Reporting System. Crude incidence (mortality) rates， age-standardized incidence (mortality) rates， truncated rates for the 35~64 age group， and cumulative rates for the 0~74 age group were calculated separately for urban and rural areas； the age-standardized rates were calculated by using Chinese standard population in 2000 and Segi’s world standard population in 1960. The Joinpoint 4.9.1.0 software was used to calculate the average annual percentage change (AAPC) of age-standardized incidence (mortality) rates of prostate cancer and analyze the changing trends. ［Results］ In 2021， the crude incidence rate of prostate cancer in Nantong City was 41.18/105， the age-standardized incidence rate by Chinese standard population (ASIRC) was 12.62/105， the age-standardized incidence rate by world standard population (ASIRW) was 12.32/105. The crude mortality rate was 13.42/105， the age-standardized mortality rate by Chinese standard population (ASMRC) was 3.40/105， and the age-standardized mortality rate by world standard population (ASMRW) was 3.56/105. The ASIRC and ASMRC in urban areas were higher than those in rural areas. The age-specific incidence rate of prostate cancer peaked in the 80~84 age group， and the age-specific mortality rate peaked in the age group of 85 years old and above. From 2013 to 2021， the ASIRC of prostate cancer in Nantong City showed an upward trend， with the AAPC of 6.86% (P<0.001). And the ASMRC of prostate cancer also showed an upward trend， with the AAPC of 3.83% (P=0.020). The incidence rates of prostate cancer in age groups of 55~59 years old， 60~64 years old， 65~69 years old， 70~74 years old， 75~79 years old， 80~84 years old and 85 years old and above all showed an upward trend (AAPC were 9.44%， 9.14%， 10.41%， 7.85%， 6.13%， 6.83% and 2.75% respectively， all P<0.05)， while only the mortality rates in age groups of 80~84 years old and 85 years old and above showed an upward trend (AAPC were 6.63% and 8.73% respectively， all P<0.05). ［Conclusion］ The disease burden of prostate cancer in Nantong City is at a relatively high level， with both the incidence and mortality rates increasing year by year. Special attention should be paid to middle-aged and elderly men， and efforts should be made to strengthen prostate cancer screening and early diagnosis and treatment. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |
|
|
|